Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Clinical Estradiol Trial in Women With Schizophrenia
This study is currently recruiting participants.
Study NCT00206570 Information provided by Bayside Health
First Received: September 13, 2005 Last Updated: February 16, 2007
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Schizophrenia
Schizoaffective Disorder
Schizophreniform Disorder
Additional conditions recognized in this trial
Disease
Psychotic Disorders
More general conditions related to this trial
Mental Disorders
Pathologic Processes
Schizophrenia and Disorders with Psychotic Features
Interventions listed in this trial
Estradiol
Additional drug interventions recognized in this trial
Antipsychotic Agents
Estradiol 17 beta-cypionate
Estradiol 3-benzoate
Estradiol valerate
Polyestradiol phosphate
More general drug interventions related to this trial
Central Nervous System Agents
Central Nervous System Depressants
Contraceptive Agents
Contraceptive Agents, Female
Estrogens
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Reproductive Control Agents
Therapeutic Uses
Tranquilizing Agents
Sponsors listed in this trial
Bayside Health
National Alliance for Research on Schizophrenia and Depression
Stanley Medical Research Institute
National Health and Medical Research Council, Australia
Back to top of Main Content
